Metis TechBio Co., Ltd. is a biotechnology company that researches and develops AI-empowered nanomaterials for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and the United States. It develops NanoForge, a suite of synergistic technologies including a novel lipid library, AI foundational models, METiSAIAgent, quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. The company also develops specialized platforms such as AiTEM, AiLNP, and AiRNA that simulate, predict, and interpret nanoscale interactions to enable the design, optimization, and validation of advanced nanomaterials and associated payloads. It offers a foundational dry-wet data layer integrated with dry-wet lab infrastructure, a model layer with METiS AI foundational models, and an application layer with METiSAgentv. It serves pharmaceutical companies, biotechnology companies, and medical research institutions. The company was formerly known as Hangzhou Jitai Pharmaceutical Technology Co., Ltd. and was incorporated in 2020. It is headquartered in Beijing, China.